Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $637,578 | $1,280,300 | $951,200 | $939,100 |
| % Growth | -50.2% | 34.6% | 1.3% | – |
| Cost of Goods Sold | $233,342 | $750,100 | $362,500 | $380,800 |
| Gross Profit | $404,236 | $530,200 | $588,700 | $558,300 |
| % Margin | 63.4% | 41.4% | 61.9% | 59.5% |
| R&D Expenses | $66,098 | $226,900 | $110,100 | $101,300 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $165,390 | $534,400 | $260,500 | $256,200 |
| Sales & Mktg Exp. | $0 | $534,400 | $0 | $0 |
| Other Operating Expenses | $0 | $139,900 | $0 | $0 |
| Operating Expenses | $231,488 | $901,200 | $370,600 | $357,500 |
| Operating Income | $172,747 | -$371,000 | $218,100 | $200,800 |
| % Margin | 27.1% | -29% | 22.9% | 21.4% |
| Other Income/Exp. Net | -$8,342 | $874,300 | -$11,700 | -$105,700 |
| Pre-Tax Income | $164,405 | $503,300 | $206,400 | $95,100 |
| Tax Expense | $41,014 | $126,100 | $53,200 | $69,800 |
| Net Income | $123,391 | $377,200 | $153,200 | $25,300 |
| % Margin | 19.4% | 29.5% | 16.1% | 2.7% |
| EPS | 0.21 | 0.64 | 0.26 | 0.042 |
| % Growth | -67.2% | 146.2% | 513.2% | – |
| EPS Diluted | 0.21 | 0.64 | 0.26 | 0.043 |
| Weighted Avg Shares Out | 586,589 | 585,543 | 589,233 | 596,768 |
| Weighted Avg Shares Out Dil | 591,229 | 590,297 | 589,386 | 593,223 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,375 | $4,300 | $0 | $3,800 |
| Interest Expense | $3,186 | $11,100 | $3,200 | $19,000 |
| Depreciation & Amortization | $43,390 | $139,900 | $57,600 | $45,600 |
| EBITDA | $210,981 | $654,300 | $275,700 | $246,400 |
| % Margin | 33.1% | 51.1% | 29% | 26.2% |